Literature DB >> 8700886

Two-hybrid system as a model to study the interaction of beta-amyloid peptide monomers.

S R Hughes1, S Goyal, J E Sun, P Gonzalez-DeWhitt, M A Fortes, N G Riedel, S R Sahasrabudhe.   

Abstract

The kinetics of amyloid fibril formation by beta-amyloid peptide (Abeta) are typical of a nucleation-dependent polymerization mechanism. This type of mechanism suggests that the study of the interaction of Abeta with itself can provide some valuable insights into Alzheimer disease amyloidosis. Interaction of Abeta with itself was explored with the yeast two-hybrid system. Fusion proteins were created by linking the Abeta fragment to a LexA DNA-binding domain (bait) and also to a B42 transactivation domain (prey). Protein-protein interactions were measured by expression of these fusion proteins in Saccharomyces cerevisiae harboring lacZ (beta-galactosidase) and LEU2 (leucine utilization) genes under the control of LexA-dependent operators. This approach suggests that the Abeta molecule is capable of interacting with itself in vivo in the yeast cell nucleus. LexA protein fused to the Drosophila protein bicoid (LexA-bicoid) failed to interact with the B42 fragment fused to Abeta, indicating that the observed Abeta-Abeta interaction was specific. Specificity was further shown by the finding that no significant interaction was observed in yeast expressing LexA-Abeta bait when the B42 transactivation domain was fused to an Abeta fragment with Phe-Phe at residues 19 and 20 replaced by Thr-Thr (AbetaTT), a finding that is consistent with in vitro observations made by others. Moreover, when a peptide fragment bearing this substitution was mixed with native Abeta-(1-40), it inhibited formation of fibrils in vitro as examined by electron microscopy. The findings presented in this paper suggest that the two-hybrid system can be used to study the interaction of Abeta monomers and to define the peptide sequences that may be important in nucleation-dependent aggregation.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8700886      PMCID: PMC39910          DOI: 10.1073/pnas.93.5.2065

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  37 in total

1.  The precursor of Alzheimer's disease amyloid A4 protein resembles a cell-surface receptor.

Authors:  J Kang; H G Lemaire; A Unterbeck; J M Salbaum; C L Masters; K H Grzeschik; G Multhaup; K Beyreuther; B Müller-Hill
Journal:  Nature       Date:  1987 Feb 19-25       Impact factor: 49.962

2.  A new class of yeast transcriptional activators.

Authors:  J Ma; M Ptashne
Journal:  Cell       Date:  1987-10-09       Impact factor: 41.582

Review 3.  Seeding "one-dimensional crystallization" of amyloid: a pathogenic mechanism in Alzheimer's disease and scrapie?

Authors:  J T Jarrett; P T Lansbury
Journal:  Cell       Date:  1993-06-18       Impact factor: 41.582

4.  Molecular cloning and characterization of a cDNA encoding the cerebrovascular and the neuritic plaque amyloid peptides.

Authors:  N K Robakis; N Ramakrishna; G Wolfe; H M Wisniewski
Journal:  Proc Natl Acad Sci U S A       Date:  1987-06       Impact factor: 11.205

5.  The carboxy terminus of the beta amyloid protein is critical for the seeding of amyloid formation: implications for the pathogenesis of Alzheimer's disease.

Authors:  J T Jarrett; E P Berger; P T Lansbury
Journal:  Biochemistry       Date:  1993-05-11       Impact factor: 3.162

6.  Alzheimer's disease and Down's syndrome: sharing of a unique cerebrovascular amyloid fibril protein.

Authors:  G G Glenner; C W Wong
Journal:  Biochem Biophys Res Commun       Date:  1984-08-16       Impact factor: 3.575

7.  Characterization and chromosomal localization of a cDNA encoding brain amyloid of Alzheimer's disease.

Authors:  D Goldgaber; M I Lerman; O W McBride; U Saffiotti; D C Gajdusek
Journal:  Science       Date:  1987-02-20       Impact factor: 47.728

8.  Amyloid plaque core protein in Alzheimer disease and Down syndrome.

Authors:  C L Masters; G Simms; N A Weinman; G Multhaup; B L McDonald; K Beyreuther
Journal:  Proc Natl Acad Sci U S A       Date:  1985-06       Impact factor: 11.205

9.  Presenile dementia and cerebral haemorrhage linked to a mutation at codon 692 of the beta-amyloid precursor protein gene.

Authors:  L Hendriks; C M van Duijn; P Cras; M Cruts; W Van Hul; F van Harskamp; A Warren; M G McInnis; S E Antonarakis; J J Martin
Journal:  Nat Genet       Date:  1992-06       Impact factor: 38.330

10.  Amyloid beta protein gene: cDNA, mRNA distribution, and genetic linkage near the Alzheimer locus.

Authors:  R E Tanzi; J F Gusella; P C Watkins; G A Bruns; P St George-Hyslop; M L Van Keuren; D Patterson; S Pagan; D M Kurnit; R L Neve
Journal:  Science       Date:  1987-02-20       Impact factor: 47.728

View more
  10 in total

1.  Three-dimensional structure of the lithostathine protofibril, a protein involved in Alzheimer's disease.

Authors:  C Grégoire; S Marco; J Thimonier; L Duplan; E Laurine; J P Chauvin; B Michel; V Peyrot; J M Verdier
Journal:  EMBO J       Date:  2001-07-02       Impact factor: 11.598

2.  VP3, a structural protein of infectious pancreatic necrosis virus, interacts with RNA-dependent RNA polymerase VP1 and with double-stranded RNA.

Authors:  Torunn Pedersen; Astrid Skjesol; Jorunn B Jørgensen
Journal:  J Virol       Date:  2007-04-11       Impact factor: 5.103

3.  Alpha2-macroglobulin associates with beta-amyloid peptide and prevents fibril formation.

Authors:  S R Hughes; O Khorkova; S Goyal; J Knaeblein; J Heroux; N G Riedel; S Sahasrabudhe
Journal:  Proc Natl Acad Sci U S A       Date:  1998-03-17       Impact factor: 11.205

4.  Inhibition of amyloid fibrillogenesis and toxicity by a peptide chaperone.

Authors:  Puttur Santhoshkumar; Krishna K Sharma
Journal:  Mol Cell Biochem       Date:  2004-12       Impact factor: 3.396

5.  Aromaticity and amyloid formation: effect of π-electron distribution and aryl substituent geometry on the self-assembly of peptides derived from hIAPP(22-29).

Authors:  Adam A Profit; Jayson Vedad; Mohamad Saleh; Ruel Z B Desamero
Journal:  Arch Biochem Biophys       Date:  2014-12-15       Impact factor: 4.013

6.  Mechanistic investigation of the inhibition of Abeta42 assembly and neurotoxicity by Abeta42 C-terminal fragments.

Authors:  Huiyuan Li; Bernhard H Monien; Aleksey Lomakin; Reeve Zemel; Erica A Fradinger; Miao Tan; Sean M Spring; Brigita Urbanc; Cui-Wei Xie; George B Benedek; Gal Bitan
Journal:  Biochemistry       Date:  2010-08-03       Impact factor: 3.162

7.  Latrepirdine (dimebon) enhances autophagy and reduces intracellular GFP-Aβ42 levels in yeast.

Authors:  Prashant R Bharadwaj; Giuseppe Verdile; Renae K Barr; Veer Gupta; John W Steele; M Lenard Lachenmayer; Zhenyu Yue; Michelle E Ehrlich; Gregory Petsko; Shulin Ju; Dagmar Ringe; Sonia E Sankovich; Joanne M Caine; Ian G Macreadie; Sam Gandy; Ralph N Martins
Journal:  J Alzheimers Dis       Date:  2012       Impact factor: 4.472

8.  Structural and functional studies of STAT1 from Atlantic salmon (Salmo salar).

Authors:  Astrid Skjesol; Tom Hansen; Cheng-Yin Shi; Hanna L Thim; Jorunn B Jørgensen
Journal:  BMC Immunol       Date:  2010-03-30       Impact factor: 3.615

Review 9.  A survey of peptides with effective therapeutic potential in Alzheimer's disease rodent models or in human clinical studies.

Authors:  N Sun; S A Funke; D Willbold
Journal:  Mini Rev Med Chem       Date:  2012-05       Impact factor: 3.862

Review 10.  Oxidative stress in Alzheimer's and Parkinson's diseases: insights from the yeast Saccharomyces cerevisiae.

Authors:  Catarina Pimentel; Liliana Batista-Nascimento; Claudina Rodrigues-Pousada; Regina A Menezes
Journal:  Oxid Med Cell Longev       Date:  2012-06-03       Impact factor: 6.543

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.